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ABSTRACT 
The commensal microbiota impacts specific immune cell populations and their functions at 
peripheral sites, such as gut mucosal tissues. However, it remains unknown whether gut microbiota 
control immunity through regulation of hematopoiesis at primary immune sites. We reveal that 
germ-free mice display reduced proportions and differentiation potential of specific myeloid cell 
progenitors of both yolk sac and bone marrow origin. Homeostatic innate immune defects may lead 
to impaired early responses to pathogens. Indeed, following systemic infection with Listeria 
monocytogenes, germ-free and oral antibiotic-treated mice display increased pathogen burden and 
acute death. Recolonization of germ-free mice with a complex microbiota restores defects in 
myelopoiesis and resistance to Listeria. These findings reveal that gut bacteria direct innate immune 
cell development via promoting hematopoiesis, contributing to our appreciation of the deep 
evolutionary connection between mammals and their microbiota.  
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C h a p t e r  1  
INTRODUCTION 
The discovery of antibiotics in the last century is one of the most significant achievements of 
modern medicine. Pathogens that once devastated entire civilizations, such as Mycobacterium 
tuberculosis, could finally be controlled, suggesting a triumph over infectious disease. However, the 
rampant rise of antibiotic resistance among pathogens, compounded by a drying pipeline of novel 
antibiotic development by pharmaceutical companies, has rendered current therapeutic strategies 
ineffective. As such, it is speculated that we are entering a post-antibiotic era where pathogens once 
again reign with limited opposition, and a minor scrape may pose the risk of a fatal infection  
(Alanis, 2005; Kahrstrom, 2013). To combat the renewed threat of pathogenic microorganisms, 
clinical approaches toward eradicating infectious disease must evolve.  
 
The recent increase in the severity and incidence of Clostridium difficile-associated diarrhea 
(CDAD) is emblematic of medicine’s current failings as well as its possible future. The disruption 
of intestinal microbiota, most commonly by antibiotics, prompts infection by C. difficile, resulting 
in disease that ranges from mild diarrhea to fulminant colitis (Bartlett, 2002). Once fatal, the advent 
of antibiotics consigned infection to a manageable disease. However, the spread of antibiotic-
resistant, hypervirulent strains in recent years has created an epidemic that is exceedingly difficult 
to manage (Loo et al., 2005). Currently, 20–25% of patients experience relapsing disease, further 
reflecting the reduced efficacy of antibiotic therapy (Bartlett, 2002). Besieged by an unrelenting 
pathogen, clinicians began to supplement patients with the fecal contents of healthy donors in an 
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attempt to reestablish the natural resistance afforded by the microbiota against C. difficile. Fecal 
transplantation embraces the hygiene hypothesis, which argues that microbial exposure, particularly 
commensal microbes, is beneficial to host health. This approach of administering microbes to 
combat disease is in shocking contrast to standard medical practices of the last century that, abiding 
by the principles of germ theory, indiscriminately target microbes as a means of promoting 
individual health. Yet, as fecal transplantation achieves a 91% primary cure rate (Brandt et al., 
2012), it insists upon a reassessment of our clinical strategy toward preventing and treating 
infectious disease and suggests a possible role of commensal microbes in mediating protection 
against pathogenic microorganisms. 
 
The commensal microbiota is primarily comprised of indigenous bacteria that colonize the external 
interfaces of its host. Co-evolution has resulted in microbes with extensive and diverse impacts on 
multiple aspects of host biology, including nutrient acquisition and immune development (Kau et 
al., 2011; Round and Mazmanian, 2009). Appropriately, conditions that disrupt the symbiotic host-
microbial coexistence significantly alter predisposition to a wide spectrum of metabolic and 
inflammatory disorders, which include diabetes, metabolic syndrome, inflammatory bowel disease, 
asthma and multiple sclerosis (Hill et al., 2012; Lee et al., 2011; Mazmanian et al., 2008; Vijay-
Kumar et al., 2010). We further advance these studies by revealing the microbiota is essential in 
maintaining immune integrity against pathogenic microbes by driving immune development within 
primary and secondary lymphoid tissues. To provide background for these studies, Chapter 2 will 
review current literature regarding the influence of commensal microbiota on host immune 
responses, particularly as it relates to promoting resistance against infectious disease. Chapter 3 will 
present new data revealing the contribution of the microbiota in maintaining systemic populations 
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of myeloid cells by driving steady-state hematopoiesis. Chapter 4 will show this influence is 
essential for promoting resistance against systemic bacterial infection. Finally, Chapter 5 will 
summarize and contextualize these new finding, as well as discuss future directions regarding how 
this work may contribute to the prevention and treatment of infectious disease.  
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C h a p t e r  2  
THE MICROBIOTA PROTECTS AGAINST INFECTION 
The development of enteric infection, following antibiotic use, has long been observed in both 
clinical practice and in animal models of disease (Bartlett, 2002). This observation suggests that the 
commensal microbiota is essential in protecting against infection by pathogenic microorganisms. 
The utilization of animal models to study the microbiota, including germ-free (GF) mice that lack 
microbial exposure, has revealed significant insight into the diverse and intricate contribution of the 
commensal microbes towards mediating resistance against infectious disease.  
 
Commensal Microbes Directly Resist Enteric Pathogens  
The commensal microbiota achieves resistance against opportunistic infection, in part by competing 
for resources required by pathogens to establish infection. GF mice are highly susceptible to enteric 
infection with Salmonella enterica serovar Typhimurium (STm), a human-specific enteric 
pathogen, and Citrobacter rodentium, a murine pathogen used to model infection with 
enterohemorragic and enteropathogenic Escherichia coli (Kamada et al., 2012; Ng et al., 2013; 
Sekirov et al., 2008). However, colonization of GF mice with isolated commensal microbes protects 
against infection by STm or C. rodentium, in part due to the enhanced glycan acquisition 
capabilities of the transferred bacteria which outcompete and eventually displace pathogenic 
microbes (Kamada et al., 2012). Alternatively,  antibiotic-depletion of the microbiota in colonized 
mice (Specific pathogen free; SPF) results in a spike in free glycans, which promotes pathogen 
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expansion and increases the risk for enteric infection (Ng et al., 2013). These findings reveal direct 
competition by commensal microbes for nutrients as a means of limiting infection by pathogens at 
sites of colonization.  
 
Recent studies show that certain enteric pathogens actively trigger host inflammation which favors 
pathogen invasion and dissemination (Lupp et al., 2007; Sekirov et al., 2008; Stecher et al., 2007). 
Further, these reports surprisingly demonstrate that pathogen-induced inflammation adversely 
affects the microbiota, depleting populations of beneficial bacteria. By reducing the numbers of 
commensal microbes via triggering inflammatory responses, pathogens have unimpeded nutrient 
access. Collectively, there is growing evidence for the notion that pathogens and symbiotic bacteria 
are engaged in an ‘evolutionary combat’, with the host serving as the battlefield. However, 
instances in which commensal microbes are unable to directly prevent invasion by pathogenic 
microbes, protection is indirectly achieved by commensal microbes through the modulation of host 
immune responses.  
 
Gut Microbes Promote Barrier Immunity  
In addition to competing with invading pathogens, the commensal microbiota directly promote host 
immune responses which are protective against infection. Immune modulation by commensal 
microbes is essential for establishing host-microbial coexistence (Round and Mazmanian, 2009). 
We now appreciate that this influence extends into supporting protection against infectious disease 
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both by promoting barrier immunity as well as priming immune defenses against pathogen insult 
(Figure 1-1). 
 
Immune modulation by the microbiota occurs through commensal-derived signals, such as 
microbial associated molecular patterns (MAMPs). Host recognition of MAMPs is achieved by 
pathogen recognition receptors (PRRs), such as Toll-like receptors (TLRs). At mucosal surfaces, 
these commensal-derived signals drive epithelial production of mucin, secretion of immunoglobulin 
A (IgA), and the expression of antimicrobial peptides (AMPs), which collectively limit microbial 
(beneficial and pathogenic) contact with mucosal tissue (Hooper and Macpherson, 2010; Moreau et 
al., 1978; Petersson et al., 2011). One such example is commensal-driven expression of RegIIIγ by 
intestinal epithelial cells (Figure 1-2). RegIIIγ is a C-type lectin that possesses antimicrobial activity 
against Gram-positive microbes (Cash et al., 2006). Expression of RegIIIγ requires TLR recognition 
of commensal MAMPs (Vaishnava et al., 2011). As such, disruption of the microbiota, as through 
antibiotic treatment, reduces production of RegIIIγ, resulting in a breakdown of barrier immunity. 
As a consequence, antibiotic-treated mice are highly susceptible to opportunistic infection with 
enteric pathogens such as vancomycin-resistant enterococcus (VRE) (Brandl et al., 2008). VRE is a 
common cause of antibiotic-associated diarrhea and, similar to C. difficile, exceedingly difficult to 
treat. However, supplementation of antibiotic-treated mice with purified MAMPs is sufficient to 
prime RegIIIγ expression and achieve resistance against infection. Herein is another example of 
how current treatment strategies predispose the host to secondary infections, and how efforts to 
maintain the integrity of the microbiota or supplement it during antibiotic treatment may be 
effective in limiting susceptibly to opportunistic pathogens.  
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The Microbiota Primes Mucosal Immune Resistance to Pathogen Invasion 
Under conditions in which barrier resistance fails, commensal microbes continue to limit pathogen 
infection and dissemination by enhancing immune clearance responses. One such means by which 
the microbiota promotes host resistance is through priming expression of interleukin-1 β (IL-1β). 
IL-1β is a proinflammatory cytokine that is expressed in an inactive form (pro-IL-1β), which is 
subsequently cleaved by caspases following inflammasome activation (Rathinam et al., 2012). 
Intestinal mononuclear phagocytes isolated from GF mice express reduced levels of pro-IL-1β, 
compared to cells isolated from mice with an intact microbiota (specific pathogen-free; SPF) 
(Franchi et al., 2012). Cleavage of pro-IL-1β into its active form occurs after challenge with 
pathogenic microorganisms, such as STm, but not following exposure to commensal microbes. This 
would suggest that commensal microbes promote pro-IL-1β expression among intestinal 
mononuclear cells, which is specifically activated following pathogen insult. This selective 
activation of proinflammatory cytokines is one possible means by which the host is able to 
distinguish between beneficial and harmful microbes. Appropriately, commensal-driven pro-IL-1β 
expression enhances resistance to enteric infection with STm. 
 
Additional mucosal immune responses are influenced by the microbiota include driving 
differentiation of T-helper 17 (Th17) cells and expression of IL-22 by intestinal NKp46
+
 cells 
(Ivanov et al., 2009; Satoh-Takayama et al., 2008). While the role of these cells in mitigating host-
commensal co-existence remains unknown, both cell types are critical in combating mucosal 
infection with C. rodentium. It appears that the microbiota may drive certain immune responses, 
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including the production of pro-IL-1β, with the primary purpose of promoting resistance to 
pathogenic infection. 
 
Commensal Microbes Prevent Infection at Colonization Sites Beyond the Gut 
While many studies investigating the contribution of the microbiota in resisting infections have 
focused within the gut, colonization by commensal microbes at other epithelial surfaces also affords 
protection against pathogenic microorganisms. Skin microbes prime local development of Th1, 
Th17 and IL-17
+
 gamma-delta T cells (Naik et al., 2012). Cutaneous T cell differentiation by 
commensal microbes is achieved through MAMP-driven IL-1β signaling. This response is 
independent of the intestinal microbiota as oral antibiotic treatment, which reduces intestinal Th1 
and Th17 cells, has no effect on the immune profile within the skin. Furthermore, colonization of 
GF mice with the prominent skin commensal Staphylococcus epidermidis is sufficient to rescue the 
defective immune response in GF mice. Priming of these immune responses by skin microbes is 
instrumental in promoting resistance against cutaneous infection with Leishmania major. Here we 
see compartmentalized immune modulation by commensal microbes leads to site-specific 
protection against infectious disease. 
 
Immune protection is also achieved by commensal microbes residing within the respiratory mucosa. 
Antibiotic-treated mice display reduced resistance to influenza infection (Ichinohe et al., 2011). 
Disease susceptibility is characterized by defective IL-1β production as well as reduced dendritic 
cell recruitment and T cell priming. As a consequence, antibiotic-treated animals display attenuated 
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T cell and B cell responses following viral infection. Interestingly, depletion of the microbiota did 
not enhance susceptibility to infection with herpes simplex virus type 2 or Legionella pneumophila, 
indicating specificity for pathogens to which the microbiota promotes resistance. Intranasal 
inoculation with purified MAMPs, such as LPS, is sufficient to restore protective immunity to 
infection, as is, surprisingly, intrarectal MAMP administration. These findings suggest that the 
imunoprotective properties of commensal microbes are not limited to the sites of colonization, but 
rather may extend to distal compartments and may even support host resistance against systemic 
infection. 
 
Commensal Microbes Promote Host Resistance to Systemic Infection 
While commensal microbes are physically restricted to external sites of colonization, their influence 
on host immune responses extends into systemic compartments. This concept was revealed with the 
finding that GF mice display a diminished splenic CD4
+
 T cell profile (Mazmanian et al., 2005). 
Monocolonization of GF mice with Bacteroides fragilis, a prominent intestinal microbe, is 
sufficient to promote CD4
+
 T cell development within the spleen. The role of commensal microbes 
in driving systemic immune maturation suggests that disruption of the microbiota may compromise 
host resistance to systemic infection.  
 
Deliberate depletion of the microbiota reduces resistance to systemic infection with Lymphocytic 
Choriomeningitis Virus (LCMV) (Abt et al., 2012). Antibiotic-treated mice display increased viral 
burden as a consequence of attenuated anti-viral immune responses following infection. 
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Macrophages isolated from antibiotic-treated mice are deficient in type I and II interferon (IFN) 
signaling, as well as in controlling viral replication ex vivo. This defect in innate immune resistance 
contributes to an impaired adaptive immune response, which includes deficient expansion and 
cytolytic activity of LCMV-specific CD8
+
 T cells, as well as reduced serum titers of anti-LCMV 
IgG. Furthermore, anti-viral immunity among microbiota-depleted mice may be further 
compromised by altered transcriptional regulation proinflammatory genes following infection. 
Splenic mononuclear cells, isolated from GF mice, demonstrate reduced production of 
proinflammatory cytokines following stimulated with purified MAMPs (Ganal et al., 2012). This 
defective response is associated with reduced transcription of various inflammatory response genes 
due to chromatin modification of the promoter region. These studies reveal a remarkable role for 
commensal microbes in programing host systemic defense responses during steady-state conditions. 
Furthermore, as this influence is reversible, temporary depletion of the microbiota is sufficient to 
compromise systemic immune resistance to pathogen invasion. 
 
In addition to priming anti-viral immune responses during steady-state conditions, commensal 
microbes may also protect against systemic bacteremia. Neutrophils isolated from the bone marrow 
of antibiotic-treated or GF mice are attenuated in killing extracellular pathogens Staphylococcus 
aureus and Streptococcus pneumonia, ex vivo (Clarke et al., 2010). This defect was reproduced in 
mice deficient in Nod1, a PRR which recognizes peptidoglycan derived meso-diaminopimelic acid 
(mesoDAP), but not in mice deficient in other PRRs. As mesoDAP is expressed by commensal 
microbes, it was speculated that the microbiota may directly prime neutrophil killing activity. 
Appropriately, peptidoglycan from intestinal microbes is detected within the bone marrow, 
indicating that commensal microbes are able to directly stimulate neutrophils within systemic 
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tissues. Furthermore, neutrophil antimicrobial activity among antibiotic-treated mice is rescued 
following stimulation with Nod1 ligand. While it remains to be shown that the absence or disruption 
of the microbiota actually reduces resistance to bacterial infection, these collective findings suggest 
that immune priming by commensal microbes is critical in promoting host resistance against 
systemic infections. 
 
Defects in Host-Microbial Symbiosis May Predicate Susceptibility to Infection 
Factors that determine an individual’s susceptibility to infectious disease remain largely unknown. 
Here we suggest that environmental and genetic influences that disrupt the microbiota or impede 
host sensing of commensal-derived signals may confer vulnerability to pathogen infection (Figure 
1-3). As discussed earlier, depletion of the microbiota through antibiotics is sufficient to 
compromise host immune function and increase the risk of opportunistic infection. Other 
environmental factors that disrupt the composition of the microbiota, including gastrointestinal 
infection or diet, additionally may serve as a risk factor for disease (Bäckhed et al., 2007; Lupp et 
al., 2007). Susceptibility to infection may even persist long after exposure to the microbiota-
disrupting agent. Tracking the intestinal commensal profile among patients taking oral antibiotics 
show a recovery in the composition of the microbiota following cessation of therapy (Dethlefsen 
and Relman, 2011).  However, there is a delay of several weeks to months between the final 
antibiotic administration and recovery of the microbiota to the pre-treatment composition. In animal 
models this delay was associated with increased susceptibility to infection, reflecting the persistent 
consequences of antibiotic therapy (Ubeda et al., 2010). Additionally, certain individuals display 
alterations for up to four years after antibiotic treatment, indicating a defect in microbiota resilience 
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(Jakobsson et al., 2010). We speculate that such a defect, while asymptomatic, may compromise the 
protective contribution of the commensal microbiota to host immunity and weaken resistance 
against pathogenic insult.   
 
Defects in host sensing of the beneficial influence of commensal microbes may also serve as a risk 
factor for disease. Nod2 is an intracellular PRR that recognizes muramyl dipeptide, a conserved 
structural moiety of bacterial peptidoglycan (Maeda et al., 2005). Nod2 signaling promotes 
expression of Paneth cell α-defensin, a class of antimicrobial peptides that, similar to RegIIIγ, limits 
microbial contact with host tissue (Kobayashi et al., 2005). As a consequence of the diminished α-
defensin production, Nod2-deficient mice display heightened susceptibility to gastroenteritis by 
Listeria monocytogenes. Furthermore, as homozygous mutations in this receptor are associated with 
increased incidence of Crohn’s disease, defects in host sensing of commensal signals may be a risk 
factor for inflammatory bowel disease (IBD) by reducing clearance of pathogenic bacteria (Maeda 
et al., 2005). Indeed, the finding that adhesive and invasive E. coli (AIEC) are tightly associated 
with the intestinal epithelium among patients with Crohn’s disease may support this notion (Eaves-
Pyles et al., 2008). 
 
Finally, the genetic selection of one’s microbiota composition may reflect individual susceptibility 
to infection. NIH Swiss (NIH) mice are naturally resistant to gastrointestinal infection with C. 
rodentium compared to C3H/HeJ (HeJ) mice, which develop lethal disease (Willing et al., 2011). 
Resistance among NIH mice is associated with increased expression of IL-22 and RegIIIβ, relative 
to HeJ mice. As the microbiota drives the expression of both antimicrobial mediators, susceptibility 
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to infection may be a function of gut bacterial community composition. To test this hypothesis, HeJ 
mice were depleted of microbiota through antibiotic treatment, and colonized with intestinal 
microbes from NIH mice. The bacterial community profile of transplanted mice was shown to 
resemble that of the NIH donor. Remarkably, transfer of commensal microbes from NIH to HeJ 
mice is sufficient to promote resistance to infection. Protection is associated with increased 
expression of IL-22 and RegIIIβ, and protection is lost following neutralization of IL-22. 
Reciprocally, transplantation of HeJ microbiota to NIH mice increased disease burden to C. 
rodentium. Finally, pups in the subsequent generation inherit the microbiomes transferred to their 
parents. Offspring display resistance patterns to C. rodentium infection relative to their microbiota 
composition, rather than their genetics. These data suggest that familial history of infectious disease 
may not only reflect the inheritance of susceptibility genes, but possibly the vertical transmission of 
a microbiota that is less protective against pathogen challenge.  
 
Conclusion 
The evidence summarized in this review suggests that disruption of the microbiota through 
environmental influences may compromise immune function, leading to increased susceptibility to 
infectious disease. These studies emphasize the importance of commensal microbes in mediating 
host immune integrity during infection with pathogenic microorganisms. While these studies have 
focused on the contribution of the microbiota in modulating functional responses by mucosal and 
systemic immune cell populations (including cytokine processing, production of antimicrobial 
peptides and phagocytic activity), little is known regarding the role of commensal microbes in 
mediating immune cell development. In the next three chapters, we present new data that 
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demonstrates that commensal microbes promote hematopoiesis to expand myeloid cells that 
populate systemic sites, and serve as a first line defense against infectious disease.  
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Figure 1-1. The Intestinal Microbiota Promotes Three Levels of Protection Against Enteric 
Infection (I) Saturation of colonization sites and competition for nutrients by the microbiota limit 
pathogen association with host tissue. (II) Commensal microbes prime barrier immunity by driving 
expression of mucin, immunoglobulin A (IgA) and antimicrobial peptides (AMPs) that further 
prevent pathogen contact with host mucosa. (III) Finally, the microbiota enhances immune 
responses to invading pathogens. This is achieved by promoting IL-22 expression by T cells and 
NKp46
+
 cells, which increases epithelial resistance against infection, as well as priming secretion of 
IL-1β by intestinal monocytes (MФ) and dendritic cells (DCs), which promotes recruitment of 
inflammatory cells into the site of infection. Under conditions in which the microbiota is absent, 
such as following antibiotic treatment, there is reduced competition, barrier resistance and immune 
defense against pathogen invasion. 
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Figure 1-2. The Commensal Microbiota Primes Barrier Immunity Direct stimulation of 
epithelial Toll-like receptors (TLRs) by commensal MAMPs primes expression of RegIIIγ (A). 
Production of RegIIIγ is essential to limit microbial contact with host mucosa. As such, defects in 
TLR function result in deficient RegIIIγ expression, which leads to an increased association of 
commensal microbes with host tissue, as well as a heightened risk of infection with enteric 
pathogens (B). Additionally, reduced TLR stimulation as a consequence of the depletion of the 
microbiota is sufficient to reduce RegIIIγ expression and render the host susceptible to infection 
(C). 
 
 
 
 
A B C  
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Figure 1-3. Disruption of Host–Microbial Symbiosis as a Risk Factor for Infectious Disease 
Exposure to pathogenic microorganisms is often insufficient to cause disease. Rather, susceptibility 
to infectious disease reflects deficient immune resistance to pathogen challenge. As such, 
exogenous and endogenous factors that directly compromise individual immune function (including 
genetic immune defects and chemotherapy) are significant risk factors for infection. We extend this 
model by proposing that the factors that disrupt the protective benefits of the commensal microbiota 
similarly compromise individual immune integrity and may predispose to infectious disease. 
18 
 
 
C h a p t e r  3  
GUT MICROBES DRIVE STEADY-STATE HEMATOPOIESIS 
The immune system begins to develop in utero, but full maturation requires both genetic and 
environmental signals that further shape immunity after birth. Lymphoid and myeloid cells develop 
largely from hematopoietic stem cells (HSCs) within primary tissues, where molecular cues 
orchestrate immune cell differentiation from uncommitted HSCs and progenitor cells via regulation 
of transcription factors and epigenetic modifications (Weissman, 1994). Additionally, certain 
phagocyte populations (including Langerhans cells and microglia), derived from embryonic 
precursors, are maintained independently of HSCs (Sieweke and Allen, 2013). Genetic 
contributions (i.e., molecular cues encoded by the host genome) to lineage commitment pathways 
that control the myeloid repertoire are well studied (Georgopoulos, 2002). However, environmental 
factors that influence hematopoiesis have not been extensively defined. Based on emerging data that 
the microbiota represents an integral environmental factor in shaping numerous features of the 
immune system, we reasoned that gut bacteria may be controlling central immunity. We report 
herein that commensal microbes promote the maintenance of both HSC and embryonic-derived 
myeloid cells during steady-state conditions. The absence of commensal microbes leads to defects 
in several innate immune cell populations (including neutrophils, monocytes and macrophages) 
within systemic sites. By controlling the differentiation of innate immune cells, the gut microbiota 
prepares the host to rapidly mount immune responses upon pathogen encounter, as germ-free and 
antibiotic treated mice are impaired in clearance of systemic bacterial infection. Our study reveals 
that gut microbes evolved to actively shape immunity at its core, via regulation of hematopoiesis. 
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Germ-free Animals Display Global Defects in Innate Immune Cells 
The commensal gut microbiota profoundly influences cellular proportions, migration and functions 
of various immune cell subsets. Recent studies have provided numerous examples illustrating how 
gut bacteria modulate innate and adaptive immune responses at mucosal surfaces during infection, 
inflammation and autoimmunity (Kamada et al., 2013; Round and Mazmanian, 2009). With such 
pervasive effects, we reasoned that the microbiota may regulate hematopoiesis—the developmental 
programming of the immune system. Initially, to determine if the microbiota has global effects on 
systemic immune cell populations, we profiled myeloid cells in the spleen of colonized (SPF; 
specific pathogen free) and germ-free (GF) mice. Indeed, GF animals display reduced proportions 
and total numbers of F4/80
hi
 and F4/80
lo
 cells compared to SPF mice (Figures 3-1A-C). F4/80
hi
 cells 
are mainly macrophages, while F4/80
lo
 splenocytes are a heterogeneous population of macrophages, 
monocytes and neutrophils (Schulz et al., 2012). Intriguingly, all three cell subsets are reduced in 
GF mice (Figure 3-2A). Furthermore, treatment of SPF mice with antibiotics also results in 
diminished myeloid cell populations in the spleen (Figure 3-2B). Thus, gut bacteria dynamically 
influence innate immune cell proportions at secondary immune sites in the periphery.  
 
Myeloid cell precursors differentiate into various phagocyte lineages that are stored in the bone 
marrow, and are a major source of cells that populate peripheral tissues (Geissmann et al., 2010). 
The reduction of splenic macrophages, monocytes and neutrophils in GF mice suggests that defects 
in host immunity may include compromised development in primary immune sites. Accordingly, 
we observed a reduction of myeloid cells within the bone marrow of GF mice (Figures 3-3A-C). A 
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similar decrease was observed in the liver, a site of alternative immune cell development (Figure 3-
2C). A global defect in myeloid cell populations in primary immune sites of GF mice demonstrates 
that gut bacteria shape the architecture of the immune system early in cellular development. 
 
Commensal Microbes Enhance Myelopoiesis  
We reasoned that reductions in several phagocytic cell subsets in GF mice may reflect a primary 
defect in the maintenance of myeloid cell populations. To test if commensal microbes promote 
myelopoiesis, we pulsed SPF and GF mice with 5-Ethynyl-2´-deoxyuridine (EdU), a thymidine 
analog, to compare the percentage of dividing leukocytes. Both F4/80
hi
 and F4/80
lo
 phagocytes from 
GF mice showed reduced EdU incorporation compared to SPF animals (Figure 3-4A, B). F4/80
hi
 
macrophages are largely derived from embryonic yolk sac progenitors and are maintained 
independently of HSCs (Schulz et al., 2012; Sieweke and Allen, 2013). F4/80
lo
 leukocytes, 
however, are of hematopoietic origin, and reduced EdU incorporation by these cells in GF mice 
indicates defects in the expansion and/or differentiation of bone marrow progenitor cells (Schulz et 
al., 2012). These studies uncover a role for commensal microbes in promoting the maintenance of 
both splenic yolk sac-derived and HSC-derived myeloid cells. 
 
The reduction of F4/80
lo
 cells in GF mice led us to further investigate the contribution of 
commensal microbes on HSCs and myeloid progenitor cells in the bone marrow. No differences 
were detected in the proportion or differentiation potential of LKS
+
 cells (HSCs and multipotent 
progenitors; MPPs), LKS
-
 cells (total lineage-restricted progenitors), or common myeloid 
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progenitor cells (CMPs) between SPF and GF mice (Figure 3-5A-F). Remarkably, GF mice are 
significantly reduced in the proportion of bone marrow granulocyte and/or monocyte progenitors 
(GMPs), identified as LKS
-
 CD34
+
 FcγRhi cells (Figure 3-6A). GMPs consist of progenitor cells, 
downstream of HSCs and CMPs during hematopoiesis, with restricted myeloid differentiation 
potential (Akashi et al., 2000). To further examine the effects of gut microbiota on innate immune 
cells, we tested if commensal microbes affect the differentiation potential and self-maintenance 
capacity of GMPs. Methylcellulose culture of LKS
-
 CD34
+
 FcγRhi cells from GF mice displayed 
reduced granulocyte (G-CFU) and monocyte (M-CFU) colony formation compared to cells from 
SPF mice (Figure 3-6B). Furthermore, LKS
-
 CD34
+
 FcγRhi cells isolated from GF mice in primary 
methylcellulose culture yielded fewer of c-Kit
+
 CD11b
-
 progenitor cells compared to SPF GMPs 
(Figure 3-6C). This suggests that the ability of GMPs to maintain cells with progenitor potential is 
defective in the absence of commensal microbes (Rodrigues et al., 2008). Consistent with this 
notion, secondary cultures of unfractionated cells derived from GF GMPs generated fewer colonies 
compared to cells isolated from SPF mice (Figure 3-6D). The commensal microbiota therefore 
promotes steady-state myelopoiesis by specifically maintaining GMP proportions and enhancing 
their differentiation into mature myeloid cells in the bone marrow. 
 
Extramedullary hematopoiesis (outside the bone marrow) further contributes to the maintenance 
and inflammatory responses of tissue-resident phagocytic cells (Jenkins et al., 2011; Massberg et 
al., 2007; Robbins et al., 2012; Swirski et al., 2009). We therefore investigated whether commensal 
microbes influence the hematopoietic potential of progenitors located in the spleen. Similar to 
GMPs from the bone marrow, splenocytes isolated from GF mice displayed reduced colony 
formation in methylcellulose compared to SPF mice, with significant reductions in both neutrophil 
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and monocyte production (Figures 3-7A-B). Overall, we conclude that the microbiota shapes innate 
immune profiles by promoting myeloid progenitor development and differentiation in the bone 
marrow and extramedullary sites, revealing that gut bacteria control immunity at its core—during 
hematopoiesis.  
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Figure 3-1. GF Mice Are Deficient in Resident Myeloid Cell Populations in the Spleen (A-C) 
Splenic phagocyte profile among SPF and GF mice. Representative flow cytometry plots (A), cell 
proportions (B), and total cell number (C) of CD11b
lo 
F4/80
hi 
and CD11b
hi
 F4/80
lo
 splenic cells in 
SPF and GF mice. For all panels, data are representative of at least 3 independent trials, with n≥ 4 
mice / group. Each symbol represents data from a single animal. Error bars represent standard error 
of mean (SEM). *p<0.05, **p<0.01.  
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Figure 3-2. GF and Antibiotic-Treated Mice Have Reduced Populations of Myeloid Cells in 
Systemic Sites (A) Frequency of splenic neutrophils (CD11b
+
 GR1
hi
 Ly6c
lo
), monocytes (CD11b
+
 
Ly6c
hi 
GR1
hi
) and macrophages (CD11b
+ 
GR1
-
 F4/80
lo
) among SPF and GF mice. (B) Frequency of 
splenic CD11b
+
 F4/80
hi
 and CD11b
+
 F4/80
lo 
phagocytes among untreated mice (Ctl) and SPF mice 
treated with oral antibiotics (Abx). (C) Frequency of liver CD11b
+
 F4/80
hi
 macrophages recovered 
from SPF or GF mice. Error bars represent SEM. Data are representative of 2-3 independent trials, 
with n≥ 4. *p<0.05, **p<0.01. PMN: polymorphonuclear cells; Mono: monocytes; MФ : 
macrophages. 
 
 
 
 
25 
 
 
 
Figure 3-3. GF Mice Are Deficient in Bone Marrow Myeloid Cell Populations (A-C) Bone 
marrow populations of neutrophils (Gr1
hi
 CD115
neg
) and monocytes (Gr1
hi
 CD115
hi
) among SPF 
and GF mice. Representative flow cytometry plots (A), cell proportions (B) and total cell number 
(C) within the bone marrow of SPF and GF mice. For all panels, data are representative of at least 3 
independent trials, with n≥ 4 mice / group. Each symbol represents data from a single animal. Error 
bars represent standard error of mean (SEM). *p<0.05, **p<0.01. PMN: polymorphonuclear cells; 
Mono: monocytes.  
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Figure 3-4. The Microbiota Promotes Expansion of Splenic Myeloid Cells The percentage of 
F4/80
hi
 CD11b
+ 
(A) and F4/80
lo 
CD11b
+ 
(B) splenocytes with incorporated EdU, following single 
dose administration. For all panels, data are representative of 2 independent trials, with n≥ 4 mice / 
group. Each symbol represents data from a single animal. Error bars represent standard error of 
mean (SEM). *p<0.05, **p<0.01.  
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Figure 3-5. GF Mice Have Normal Proportions and Differentiation Potential of HSCs and 
Early Myeloid Progenitors in the Bone Marrow (A) Proportion of LKS
+
 cells (Lin
- 
c-Kit
+ 
Sca-1
+
; 
HSCs and MPPs), (B) LKS
-
 cells (Lin
-
 c-Kit
+
 Sca-1
-
; lineage-restricted progenitors) and (C) CMPs 
(LKS-CD34
+
 FcγRlo) among total progenitors (Lin- cells) of SPF and GF mouse bone marrow. (D-
F) Unfractionated bone marrow progenitor cells (Lin
-
 cells) from SPF and GF mice cultured in 
methylcellulose to assess the colony forming potential of progenitors. (D) E-CFU; erythrocyte 
colony forming units, (E) Meg-CFU; megakaryocyte CFU, (F) GEMM-CFU; 
Granulocyte/erythrocyte/monocyte/megakaryocyte CFU. Error bars represent SEM. Data are 
representative of 3 independent trials, with n≥ 4. Error bars represent SEM. ns: non-significant.  
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Figure 3-6. The Microbiota Directs Myelopoiesis (A) The frequency of LKS
-
 CD34
+
 FcγRhi 
granulocyte and/or monocyte progenitors (GMPs) among lineage negative (Lin
-
) progenitors from 
bone marrow of SPF and GF mice, as assessed by flow cytometry. (B) Distribution of cell types 
following purified LKS
-
 CD34
+
 FcγRhi cell culture in methylcellulose medium. Colonies were 
identified and counted to assess the proportion of granulocyte-monocytes (GM-CFU; black), 
granulocytes (G-CFU; blue) and monocytes (M-CFU; green). (C) Total numbers of c-Kit
+ 
CD11b
-
 
progenitors from methylcellulose cultures of LKS
-
 CD34
+
 FcγRhi progenitors, as assessed by flow 
cytometry. (D) Cells harvested from methylcellulose cultures of LKS
-
 CD34
+
 FcγRhi progenitors 
were re-plated at equal numbers in fresh methylcellulose, and cultured to assess their colony 
forming capacity. For each panel, data are representative of at least 2-3 independent trials, with n≥ 4 
/ group. Each symbol represents data from a single animal. Error bars represent SEM. *p<0.05 for 
all panels. **p<0.05 (comparing total CFU between SPF and GF for (B)), ***p<0.05 (comparing 
G-CFU between SPF and GF for (B)), ****p<0.05 (comparing M-CFU between SPF and GF for 
(B)). CFU: colony forming units.  
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Figure 3-7. Commensal Microbes Promote Extramedullary Hematopoiesis (A and B) Splenic 
cells isolated from SPF and GF mice were cultured in methylcellulose to assess the colony forming 
capacity of progenitors from SPF and GF mice. Total CFUs (A), and GM-CFUs, G-CFUs and M-
CFUs (B) are shown. For each panel, data are representative of at least 2-3 independent trials, with 
n≥ 4 / group. Each symbol represents data from a single animal. Error bars represent SEM. *p<0.05 
for all panels. **p<0.05 (comparing total CFU between SPF and GF for (B)), ***p<0.05 
(comparing G-CFU between SPF and GF for (B)), ****p<0.05 (comparing M-CFU between SPF 
and GF for (B)). CFU: colony forming units.  
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C h a p t e r  4  
MICROBIOTA-DRIVEN HEMATOPOIESIS PROTECTS AGAINST SYSTEMIC 
INFECTION 
Commensal microbes have previously been shown to influence functional responses by various 
phagocytic cells during bacterial and viral infection (Clarke et al., 2010; Franchi et al., 2012; 
Ganal et al., 2012; Ichinohe et al., 2011). However, the role of the microbiota in promoting 
hematopoiesis, and its contribution towards host health, has not been previously studied. As 
revealed in Chapter 3, naïve GF animals display reductions in both proportions and total cell 
numbers of tissue-resident F4/80
hi
 and F4/80
lo
 phagocytes compared to SPF mice (Figures 3-1A-
C). Furthermore, treatment of SPF mice with antibiotics also results in diminished resident 
phagocytic cells (Figure 3-2B). Tissue-resident cells are essential in mediating acute resistance 
against pathogenic microorganisms by restricting bacterial dissemination, as well as coordinating 
the recruitment of additional immune cells to the site of infection (Pamer, 2004; Sieweke and 
Allen, 2013). Therefore, we investigated whether the reduced populations of these phagocytic 
cells, as a consequence of absent or diminished colonization by commensal microbes, increases 
susceptibility to infectious disease.  
 
Tissue-Resident Phagocytes Mediate Protection by Commensal Microbes 
We sought to test the impact of commensal microbes on myeloid cell differentiation by employing 
infection models where innate immunity is vital for an effective immune response. SPF and GF 
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mice were infected intravenously (i.v.) with the model pathogen, Listeria monocytogenes. SPF mice 
challenged systemically with L. monocytogenes effectively control infection, as previously 
described (Figure 4-1A) (Serbina et al., 2012; Shi et al., 2011). However, GF mice rapidly succumb 
at the same inoculum (Figure 4-1A). Heightened susceptibility to infection among GF mice was 
associated with a significant increase in splenic and liver bacterial burden 24 and 72 hours post-
infection (hpi), demonstrating a defect in early resistance to Listeria infection (Figures 4-1B-D). 
Susceptibility to infection is not restricted to L. monocytogenes, as GF mice also displayed 
increased disease burden following systemic challenge with Staphylococcus aureus (Figure 4-1E). 
Interestingly, SPF mice treated orally with broad-spectrum antibiotics are also impaired in 
controlling Listeria, indicating that protection by commensal microbes is an active process and is 
subject to loss following depletion of gut microbiota (Figure 4-1F). Collectively, these data reveal 
that commensal microbes are critical for rapid and potent systemic immune responses to acute 
bacterial infection. 
 
To confirm that defects in myelopoiesis contribute to increased disease burden in GF mice, 
phagocytic cells were depleted with clodronate-loaded liposomes (CL) prior to infection with L. 
monocytogenes (van Rooijen et al., 1996). CL pre-treatment increased susceptibility to Listeria 
infection (Figure 4-2A,B), confirming the importance of resident cells in pathogen resistance 
(Aichele et al., 2003; Kastenmuller et al., 2012). Importantly, depletion of resident phagocytes 
rendered both SPF and GF mice equally susceptible to infection, resulting in similar splenic disease 
burden 24 hpi (Figure 4-2A), and rapid death within 48 hpi (Figure 4-2B). While functional defects 
in myeloid cells may potentially contribute to increased disease in GF mice, we did not detect 
differences during in vitro Listeria killing by macrophages from SPF or GF mice (Figure 4-2C). 
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Furthermore, CD11b
+
 myeloid cells isolated from either SPF or GF donors were equally sufficient 
in providing protection when transferred into GF mice prior to infection (Figure 4-2D), suggesting 
that reduced cell proportions are likely the primary defect in GF mice. These studies confirm the 
importance of microbiota-driven myelopoiesis in promoting host resistance during systemic 
infection.  
 
Effective responses to L. monocytogenes requires coordination between innate and adaptive 
immune cells, resulting in pathogen clearance and protective immunity (Pamer, 2004). Thus, we 
investigated whether additional immune cells beyond tissue-resident phagocytes may mediate 
commensal-derived protection to Listeria infection. We show that adaptive immunity is not 
required for protection by the microbiota during acute infection (Figure 4-3A), nor are GF mice 
deficient in developing long-term protective immunity against subsequent infection (Figure 4-3B). 
Furthermore, the selective expansion of myeloid cells during acute infection (called emergency 
hematopoiesis) which is necessary for mediating delayed resistance to L. monocytogenes (following 
48 hpi), was maintained in GF mice (Figure 4-3C) (Serbina et al., 2009; Serbina et al., 2003). 
Finally, while there are fewer inflammatory neutrophils and monocytes recruited to the spleen 
following infection (Figure 4-3D), a possible consequence of increased apoptosis (Figure 4-3E), 
these cells were not required for commensal-mediated protection against L. monocytogenes (Figure 
4-3F, G). Together, these findings demonstrate that hematopoietic defects in tissue-resident myeloid 
cells prior to infection of GF mice (i.e., during steady-state hematopoiesis) is the primary cause of 
impaired control of Listeria. 
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Commensal Bacterial Signals Mediate Maintenance of Myelopoiesis 
The molecular mechanism(s) by which commensal microbes promote steady-state expansion of 
bone marrow- and yolk sac-derived myeloid cells remains unknown. Microbial associated 
molecular patterns (MAMPs) and microbial metabolites, such as short chain fatty acids (SCFAs), 
have been shown to modulate various aspects of the host immune response (Chu and Mazmanian, 
2013; Clarke et al., 2010; Smith et al., 2013). Furthermore, MyD88 (an adaptor for recognition of 
many MAMPs) was recently shown to promote GMP expansion and differentiation (Fiedler et al., 
2013). Accordingly, we sought to address whether commensal-derived factors are involved in the 
maintenance of myeloid cells under naïve conditions. Recolonization of GF mice with a complex 
microbiota and oral treatment with MAMPs, but not SCFAs, was sufficient to promote recovery of 
GMP-derived myeloid cells (neutrophils and monocytes) within the bone marrow (Figure 4-4A, B). 
Importantly, only recolonization of GF mice with an SPF microbiota was sufficient to restore 
splenic populations of F4/80
hi
 macrophages and F4/80
lo
 splenocytes (i.e., neutrophils, monocytes 
and macrophages) (Figure 4-4C and data not shown). Therefore, while MAMP treatment is 
necessary for the maintenance of bone marrow-derived myeloid cells, colonization with a live and 
complex microbiota is required to promote complete myelopoiesis (including yolk sac-derived 
macrophages). Finally, only recolonization of GF animals, and not oral MAMP treatment, was 
sufficient to restore the defect in GF mice to systemic challenge with L. monocytogenes (Figure 4-
4D and data not shown). Collectively, these studies reveal that the microbiota provides complex 
molecular signals that actively promote the hematopoietic differentiation of myeloid cells, resulting 
in peripheral phagocyte populations that function as sentinels for the early detection and control of 
systemic bacterial infection.   
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Figure 4-1. The Microbiota Promotes Early Resistance to Systemic Infection (A-C) SPF and 
GF mice were infected with L. monocytogenes and assessed for survival (A) and splenic bacterial 
burden at 24 (B) and 72 (C) hours post- infection (hpi). (D) Liver bacterial burden among SPF and 
GF mice, 72 hpi. (E) SPF and GF mice infected with S. aureus. Kidney bacterial burden assessed 5 
days post-infection . (F) SPF mice treated with antibiotics (Abx) and untreated controls (Ctl) were 
infected with L. monocytogenes and splenic bacterial burden was measured 72 hpi. For all panels, 
data are representative of at least 2-3 independent trials, with n≥ 4 / group. Each symbol represents 
data from a single animal. Error bars represent SEM. *p<0.05, **p<0.01, *** p<0.05 log-rank test 
used for survival curves in (A). 
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Figure 4-2. The Microbiota Promotes Resistance to Infection via Tissue-Resident Cells (A-C) 
SPF and GF mice depleted of tissue-resident cells prior to infection with L. monocytogenes and 
assessed for splenic bacterial burden 24 hpi (A) and survival (B). (C) Peritoneal macrophages 
isolated from SPF or GF mice, untreated or stimulated with interferon-γ (IFNγ), infected with L. 
monocytogenes. Recovery of intracellular bacteria measured over time. Data is non-significant for 
all time points measured, except where indicated (untreated SPF vs. GF, 4 hpi). (D) Splenic 
bacterial burden, 24 hpi, following transfer of splenic CD11b
+
 cells from SPF or GF donors . For all 
panels, data are representative of at least 2-3 independent trials, with n≥ 4 / group. Each symbol 
represents data from a single animal. Error bars represent SEM. *p<0.05, **p<0.01. CL: 
clodronate-loaded liposomes.  
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Figure 4-3. Resident Phagocytes Mediated Commensal-Enhanced Protection Against 
Infectious Disease (A) SPF and GF Rag
-/-
 mice infected with L. monocytogenes, splenic bacterial 
burden assessed 72 hpi. (B) SPF and GF mice were immunized with L. monocytogenes ΔactA. 45 
days after immunization, SPF and GF mice, as well as naïve, non-immunized SPF controls, were 
infected with wild-type (WT) L. monocytogenes. Splenic bacteria burden of the WT strain was 
measured at 72 hpi. Note: two of the four naïve, non-immunized SPF mice died following infection, 
prior to the 72 hour time point (data not shown). (C) BrdU incorporation among bone marrow 
neutrophils (CD11b
+ 
GR1
hi 
) and monocytes (CD11b
+
 CD115
+
), 72 hpi. (D) Percentage of splenic 
neutrophils (Gr1
hi
 Ly6C
lo
) and monocytes (Gr1
hi
 Ly6C
hi
) among SPF and GF mice, 72 hpi. (E) 
Annexin V
+
 bone marrow monocytes, 72 hpi. (F) SPF and GF mice infected with L. 
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monocytogenes, following neutrophil depletion. Splenic bacterial burden assessed at 72 hpi. (G) 
Splenic bacterial burden of SPF and GF mice, reconstituted with bone marrow from WT or CCR2
-/- 
mice, 72 hpi. SPF mice reconstituted with CCR2
-/-
 bone marrow display a two-fold reduction in 
splenic CFUs compared to GF CCR2
-/-
 mice. For all panels, data are representative of 2-3 
independent trials, with n≥ 4/ group. Each symbol represents data from a single animal. Error bars 
represent SEM. *p<0.05, **p<0.01. PMN: polymorphonuclear cells; Mono: monocytes.  
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Figure 4-4. Recolonization of GF Mice Restores Immune Integrity Against Systemic 
Listeriosis (A) Neutrophil (GR1
hi 
CD115
-
) and (B) monocyte (GR1
hi 
CD115
+
) bone marrow 
profiles from SPF, GF, recolonized GF mice and MAMP or SCFA-treated GF mice. (C) F4/80
hi 
splenic macrophage profile among SPF, GF, recolonized GF mice and GF mice treated with 
MAMPs or SCFAs. (D) Splenic bacterial burden 72 hpi among SPF, GF and recolonized GF mice 
infected with L. monocytogenes. For all panels, data are representative of at least 2 independent 
trials, with n≥4 / group. Each symbol represents data from a single animal. Error bars represent 
standard error of mean (SEM). *p<0.05, **p<0.01. Recol: recolonized; MAMPs: molecular 
associated molecular patterns; SCFAs: short chain fatty acids.  
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C h a p t e r  5  
FINDINGS AND DISCUSSION 
Advances in understanding host-microbial symbiosis have revealed that the gut microbiota control 
the phenotype, migration and activity of multiple innate and adaptive immune cells (Belkaid and 
Naik, 2013; Chu and Mazmanian, 2013). Disruption or alteration of commensal communities 
impacts host susceptibility to various disorders, particularly at sites of microbial colonization such 
as the intestines, respiratory mucosa and skin epithelium (Kamada et al., 2013). In addition to 
modulating functional immune outcomes, the microbiota is necessary for maintaining circulating 
populations of neutrophils and CD4
+
 T cells in the spleen (Bugl et al., 2013; Mazmanian et al., 
2005), suggesting a possible contribution by gut microbiota to the development of the immune 
system. Herein, we reveal that gut bacteria regulate hematopoiesis within primary immune sites, 
providing a unifying explanation for previous observations of the widespread effects by the 
microbiota on the immune system.  
 
Our study uncovers that the microbiota promotes steady-state myeloid cell development by driving 
the expansion of yolk sac-derived macrophages, as well as enhancing the numbers and 
differentiation potential of GMPs in the bone marrow. Furthermore, as a consequence of the 
reduced populations of resident phagocytes, which serve as a first line defense against invading 
pathogens, GF mice are more susceptible to systemic infection with L. monocytogenes. Interesting, 
despite multiple immune abnormalities having been previously described in GF mice, the increased 
susceptibility to systemic infection with L. monocytogenes appears to be specific to the reduced 
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proportions of resident myeloid cells. Previous studies have shown that commensal microbes prime 
neutrophil killing of Streptococcus pneumoniae and Staphylococcus aureus (Clarke et al., 2010). 
Further, the microbiota enhances host resistance to viral infection by promoting expression of type-
1 interferon by splenic phagocytes (Abt et al., 2012). However, we were not able to detect defects in 
the functional activity of phagocytes isolated from GF mice, as related to protection against L. 
monocytogenes. Peritoneal macrophages isolated from naïve SPF and GF mice displayed equivalent 
killing of Listeria, ex vivo. Additionally, SPF and GF phagocytes expressed similar levels of TNFα 
and NO following infection, which is essential for limiting Listeria dissemination (data not shown). 
Finally, splenic phagocytes isolated from SPF and GF donors were equally sufficient to provide 
protection against infection when transferred into GF recipients. These data suggests that a primary 
defect in the maintenance of resident phagocytes in GF animals is responsible for the increased 
susceptibility to systemic infection. However, it remains possible that the microbiota primes 
additional immune responses, not described here, that further contributes to mediating host 
protection against infectious disease.   
 While our studies reveal steady-state hematopoiesis is compromised in GF mice, emergency 
hematopoiesis, or the selective expansion of myeloid cell following infection, is maintained 
independent of commensal microbes. One possible explanation for this contrast is that the 
expression of cytokines and growth factors following infection, as well as direct stimulation by 
microbial ligands, may rescue hematopoietic defects in GF mice otherwise present under steady-
state/non-inflammatory conditions. We propose a model whereby a primary defect in hematopoiesis 
in GF or antibiotic-treated mice compromises multiple tissue-resident innate immune cell 
populations prior to infection, leading to blunted early responses upon subsequent pathogen 
encounter (see diagram in Figure 5-1). While tissue-resident phagocytes directly mediate early 
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resistance to infection, these cells are also essential for recruiting additional phagocytes 
(monocytes) which is essential for maintaining resistance  (Coombes et al., 2012; Kastenmuller et 
al., 2012). GF mice therefor display exacerbated disease severity as a consequence of diminished 
phagocyte recruitment into infected tissues. While our studies focus on innate immunity due to its 
role in rapid control of early Listeria infection, impaired microbiota-mediated hematopoiesis may 
also extend to the adaptive immune system, providing an explanation for observations that 
peripheral T, B and iNKT cell populations are altered in GF mice (Ivanov et al., 2008; Macpherson 
and Uhr, 2004; Mazmanian et al., 2005; Olszak et al., 2012).  
 
How commensal microbes (presumably in the gut) are able to control immune responses in distant 
sites such as the bone marrow remains incompletely understood. It has recently been shown that 
mice deficient in MyD88 signaling display reductions in systemic myeloid cell populations and 
GMP numbers (Fiedler et al., 2013; Yanez et al., 2013), similar to our findings in GF mice. Further, 
as microbial ligands are detected in systemic sites, including the bone marrow (Clarke et al., 2010), 
commensal-derived MAMPs that originate in the gut may mediate steady-state myelopoiesis in 
primary immune sites. Accordingly, we show that oral treatment with MAMPs is sufficient to 
rescue GMP-mediated expansion of neutrophils and monocytes in GF mice. However, MAMP 
treatment alone is inadequate to expand splenic F4/80
hi
 and F4/80
lo
 cells, indicating that additional 
commensal-derived signals are necessary to influence site-specific HSC- and yolk sac-derived 
myeloid cells. Interestingly, recolonization of adult GF mice with SPF microbiota is insufficient to 
restore splenic F4/80
hi
 macrophages to the levels found in SPF mice. This may suggest that 
complete rescue requires either colonization from birth or colonization with specific microbes that 
were not transferred into GF mice. In addition to microbial ligands or metabolites translocating 
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from the gut into the circulation to directly stimulate progenitor cells, other explanations for how the 
microbiota affects hematopoiesis may include a role for myeloid cell growth factors. In support of 
this notion, preliminary data suggest that GF mice are reduced in M-CSF transcript levels in the gut 
(data not shown), though further work is need to uncover the complex molecular mechanism(s) by 
which commensal bacteria signal from the gut to distant primary immune organs.  
 
Finally, we speculate that these findings may be relevant to human infections. Evidence that 
depletion of the microbiota leads to transient immune suppression suggests factors that disrupt 
commensal microbes, including that clinical antibiotic use may, paradoxically, be a risk factor for 
susceptibility to opportunistic pathogens. Furthermore, the spread of antibiotic-resistance among 
pathogens, paired with a dwindling supply of effective antibiotics, has necessitated alternative 
strategies to combat infections (Khosravi and Mazmanian, 2013). As certain commensal microbes 
have been previously shown to express molecules with unique immunomodulatory properties, it is 
possible such microbial products may be developed into therapeutics to treat infectious diseases. 
Whereas traditional antibiotics work by through direct microbicidal activity, indiscriminately killing 
both pathogenic and commensal microbes, immunomodulatory therapeutics would enhance host 
immune responses to promote pathogen clearance. Such a strategy may specifically target 
pathogenic microbes and thereby reduce the risk of secondary inflammatory disease caused by 
depleting commensal microbial communities, as currently occurs with antibiotic use. The concepts 
proposed herein, if validated in humans, may herald future medical approaches that combine 
antibiotics with immunomodulatory microbial molecules as revolutionary combination treatments 
to address the reemerging crisis of infectious diseases.  
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Figure 5-1. A Proposed Model For How the Microbiota Mediates Host Resistance to Systemic 
Infection Commensal microbes stimulate bone marrow and splenic myelopoiesis during naïve 
conditions (in the absence of infection), expanding systemic pools of mature myeloid cells in SPF 
mice that are essential for restricting pathogen dissemination upon acute infection. GF mice have 
reduced proportions and differentiation potential by GMPs during the steady-state, as well as 
diminished expansion of yolk sac-derived macrophages, impairing the immune response to 
infection with L. monocytogenes. This model suggests that conditions under which the microbiota is 
disrupted may result in deficient expansion of myeloid cells, compromising host resistance to 
infectious disease.  
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M a t e r i a l  a n d  M e t h o d s  
Animal Studies 
Specific pathogen-free (SPF) C57BL/6 
 
mice were purchased from Taconic Farms. Germ-free (GF) 
C57BL/6 and C57BL/6 Rag
-/- 
mice were bred and raised in sterile gnotobiotic flexible film isolators 
at the California Institute of Technology. Mice at 8-12 weeks of age were infected via retro-orbital 
injection with 3x10
4
 colony forming units (CFU) of Listeria monocytogenes 10403S. Splenic and 
liver bacterial CFU were assessed 24-72 hpi by microbiological plating. In some experiments, SPF 
and GF mice were immunized with 3x104 CFU L. monocytogenes ΔactA (Lara-Tejero and Pamer, 
2004), and immunized mice and non-immunized controls were infected with 2x105 CFU of wild-
type (WT) L. monocytogenes 45-day post immunization, with splenic bacterial burden measured 72 
hpi. Alternatively, SPF and GF mice were infected with 1x10
7
 CFU of S. aureus (strain Newman) 
via tail vein injection and kidney bacterial burden assessed 5 days post-infection. For microbiota 
depletion studies, SPF mice were treated with 1 mg/ml of ampicillin (Auromedics), neomycin 
sulfate (Fisher), streptomycin (Sigma) and 0.5 mg/ml of vancomycin (Sagent) in the drinking water 
for 4-5 weeks. Mice were taken off antibiotics 4 days prior to infection. Antibiotic-treated and 
untreated SPF mice were infected with 3x10
4
 CFU of L. monocytogenes, and splenic bacterial 
burden was assessed 72 hpi. GF mice were recolonized by gavage with cecal contents of SPF mice. 
Alternatively, GF mice were treated with MAMPs through the addition of heat killed Escherichia 
coli strain Nissle (Lodinova-Zadnikova and Sonnenborn, 1997) or autoclaved cecal contents from 
SPF mice in water (~1x10
9
 CFU/ml in drinking water). For treatment with short chain fatty acids, 
sodium proprionate (Sigma), sodium butyrate (Sigma), and sodium acetate (Sigma) was added to 
drinking water at previously described concentrations (25mM, 40mM and 67.5mM, respectively) 
45 
 
 
(Smith et al., 2013). Mice were recolonized or treated with microbial ligands or metabolites for 4 
weeks prior to cellular analysis and infectious studies. Animals were cared for under established 
protocols and IACUC guidelines from the California Institute of Technology. 
 
Cellular Analysis 
Spleens were either mechanically disrupted via passage through 100 µm mesh filters (BD 
Biosciences) or digested in 0.5 mg/ml of Collagenase D (Roche) and 0.5 mg/ml of DNase I 
(Worthington). Bone marrow was collected by flushing femurs with PBS containing 0.5% BSA and 
5mM EDTA. Single cell suspensions were removed of red blood cells (RBC lysis buffer, Sigma). 
Mature myeloid cells were evaluated by staining with antibodies to GR1 (RB6-8C5), Ly6C (HK 
1.4), CD11b (M1/70), CD115 (AFS98) and F4/80 (BM8). Mouse hematopoietic stem and 
progenitor cells (HSPCs) were isolated from bone marrow by a combination of MACS magnetic 
bead purification (Miltenyi) and fluorescence activated cell sorting (FACS). Lineage marker-
negative cells (Lin
-
) were first separated using a MACS lineage cell depletion kit (containing 
antibodies against CD5 (53-7.3), CD45R (B220; RA3-6B2), CD11b, Gr-1, 7-4 (15BS) and Ter-119 
(Ter-119)) and an autoMACS Separator (Miltentyi). Lin
-
 cells were then further stained with c-Kit 
(CD117; 3C1), Sca-1 (D7), CD16/CD32 (93), CD34 (RAM34). Populations of LKS
+
 cells (Lin
-
 c-
Kit
+
 Sca-1
+
; HSCs and MPPs), Lin
-
 c-Kit
+
 Sca-1
-
 (LKS
-
) CD34
+
 FcγRlo cells (CMPs) and LKS- 
CD34
+
 FcγRhi cells (GMPs) were analyzed by flow cytometry. LKS- CD34+ FcγRhi cells were 
FACS sorted using an Aria cell sorter (BD Biosciences). Steady-state cell proliferation was 
measured by intraperitoneal (i.p.) injection of 500 µg EdU (Life Technologies) and EdU 
incorporation among splenic myeloid cells was measured 24 hours later via Click-it EdU assay kit 
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(Life Technologies). To measure cell proliferation during Listeria infection, mice were injected i.p. 
with 100 µg BrdU (Sigma), and BrdU incorporation among progenitor and mature myeloid cells 
was determined 3 hours later via a BrdU detection kit (eBioscience). Apoptosis and cell viability 
was assessed by staining with Annexin V (eBioscience) and 7-Aminoactinomycin-D (Invitrogen). 
Listeria-killing assays were conducted as previously described (Portnoy et al., 1989). Briefly, 
peritoneal macrophages were collected from naïve SPF and GF mice. Adherent cells were 
stimulated with 100 U/ml of interferon gamma (IFNγ) (PeproTech) or left untreated for 24 hours. 
Macrophages were washed and infected with L. monocytogenes at a multiplicity of infection (MOI) 
of 10. Cells were washed 30 minutes later and fresh media with 5 μg/ml of Gentamycin (Phoenix) 
was added. Cells were washed and lysed at various time points to quantitate intracellular Listeria 
via microbiological plating. Antibodies were purchased from eBioscience, BD Bioscience, Miltenyi 
or Biolegend. Data were collected on a FACSCalibur or LSR Fortessa (BD Bioscience) and 
analyzed with FlowJo software (TreeStar).  
 
Cell Depletion and Adoptive Transfer 
Resident phagocytes were depleted by intravenous (i.v.) treatment with 100 μl of clodronate-loaded 
liposomes (CL; FormuMax) 48 hours prior to infection. CD11b
+
 splenocytes were isolated from 
naïve SPF and GF mice using CD11b microbeads (Miltenyi). 2x10
6
 CD11b
+
 cells (>90% purity) 
were transferred into GF recipients 24 hours prior to infection with L. monocytogenes. CFU burden 
were assessed 24 hpi. CCR2
-/- 
chimeras were generated by transferring bone marrow from WT or 
CCR2
-/-
 donors into SPF or GF recipients that had been lethally irradiated (1000 rads) 48 hours 
prior. Mice were infected with 3x104 CFU of L. monocytogenes 8 weeks post reconstitution, and 
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splenic bacterial burden was assessed 72 hpi. For neutrophil depletion, SPF and GF mice were 
injected i.p. with 0.5 mg of anti-Ly6G antibody (Bioxpress), or saline control, 24 hours prior to 
infection with L. monocytogenes. 
 
CFU Assays 
To evaluate hematopoietic potential, 1×10
3
 Lin
-
 or 1x10
3
 LKS
-
 CD34
+
 FcγRhi cells or 2x105 
splenocytes were plated in triplicate in MethoCult GF M3434 (StemCell Technologies) 
methylcellulose-based medium and incubated for 7 days in 37
o
C with 5% CO2, after which the 
colonies were counted on the basis of their morphological characteristics in accordance with the 
manufacturer’s instructions. On the same day, cells were harvested, counted and stained for c-Kit 
and CD11b expression for progenitor quantification by flow cytometry. For re-plating assays, 5x10
4
 
cells from the first culture were plated in triplicate in a secondary culture of fresh MethoCult GF 
M3434, and colonies were counted after 7 days of incubation. 
 
 
 
 
 
48 
 
 
B i b l i o g r a p h y  
 
The work presented in Chapters 1-5 is collected from published articles (Khosravi and Mazmanian, 
2013) and (Khosravi et al., 2014). 
Abt, Michael C., Osborne, Lisa C., Monticelli, Laurel A., Doering, Travis A., Alenghat, T., 
Sonnenberg, Gregory F., Paley, Michael A., Antenus, M., Williams, Katie L., Erikson, J., et al. 
(2012). Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity. 
Immunity 37, 158-170. 
Aichele, P., Zinke, J., Grode, L., Schwendener, R.A., Kaufmann, S.H., and Seiler, P. (2003). 
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate 
antigen but dispensable for induction of specific T cell responses. J Immunol 171, 1148-1155. 
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A clonogenic common 
myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197. 
Alanis, A.J. (2005). Resistance to Antibiotics: Are We in the Post-Antibiotic Era? Archives of 
Medical Research 36, 697-705. 
Bäckhed, F., Manchester, J.K., Semenkovich, C.F., and Gordon, J.I. (2007). Mechanisms 
underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the 
National Academy of Sciences 104, 979-984. 
Bartlett, J.G. (2002). Clinical practice. Antibiotic-associated diarrhea. The New England journal 
of medicine 346, 334-339. 
49 
 
 
Belkaid, Y., and Naik, S. (2013). Compartmentalized and systemic control of tissue immunity 
by commensals. Nat Immunol 14, 646-653. 
Brandl, K., Plitas, G., Mihu, C.N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R.P., 
and Pamer, E.G. (2008). Vancomycin-resistant enterococci exploit antibiotic-induced innate 
immune deficits. Nature 455, 804-807. 
Brandt, L.J., Aroniadis, O.C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., 
Rohlke, F., and Surawicz, C. (2012). Long-term follow-up of colonoscopic fecal microbiota 
transplant for recurrent Clostridium difficile infection. The American journal of 
gastroenterology 107, 1079-1087. 
Bugl, S., Wirths, S., Radsak, M.P., Schild, H., Stein, P., André, M.C., Müller, M.R., Malenke, E., 
Wiesner, T., Märklin, M., et al. (2013). Steady-state neutrophil homeostasis is dependent on 
TLR4/TRIF signaling. Blood 121, 723-733. 
Cash, H.L., Whitham, C.V., Behrendt, C.L., and Hooper, L.V. (2006). Symbiotic Bacteria 
Direct Expression of an Intestinal Bactericidal Lectin. Science 313, 1126-1130. 
Chu, H., and Mazmanian, S.K. (2013). Innate immune recognition of the microbiota promotes 
host-microbial symbiosis. Nat Immunol 14, 668-675. 
Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y., and Weiser, J.N. (2010). 
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate 
immunity. Nat Med 16, 228-231. 
Coombes, Janine L., Han, S.-J., van Rooijen, N., Raulet, David H., and Robey, Ellen A. (2012). 
Infection-Induced Regulation of Natural Killer Cells by Macrophages and Collagen at the 
Lymph Node Subcapsular Sinus. Cell Reports 2, 124-135. 
50 
 
 
Dethlefsen, L., and Relman, D.A. (2011). Incomplete recovery and individualized responses of 
the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 
108 Suppl 1, 4554-4561. 
Eaves-Pyles, T., Allen, C.A., Taormina, J., Swidsinski, A., Tutt, C.B., Jezek, G.E., Islas-Islas, 
M., and Torres, A.G. (2008). Escherichia coli isolated from a Crohn's disease patient adheres, 
invades, and induces inflammatory responses in polarized intestinal epithelial cells. 
International journal of medical microbiology : IJMM 298, 397-409. 
Fiedler, K., Kokai, E., Bresch, S., and Brunner, C. (2013). MyD88 is involved in myeloid as 
well as lymphoid hematopoiesis independent of the presence of a pathogen. American journal 
of blood research 3, 124-140. 
Franchi, L., Kamada, N., Nakamura, Y., Burberry, A., Kuffa, P., Suzuki, S., Shaw, M.H., Kim, 
Y.G., and Nunez, G. (2012). NLRC4-driven production of IL-1beta discriminates between 
pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol 13, 
449-456. 
Ganal, Stephanie C., Sanos, Stephanie L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., 
Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P., et al. (2012). Priming of Natural Killer Cells 
by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal 
Microbiota. Immunity 37, 171-186. 
Geissmann, F., Manz, M.G., Jung, S., Sieweke, M.H., Merad, M., and Ley, K. (2010). 
Development of Monocytes, Macrophages, and Dendritic Cells. Science 327, 656-661. 
Georgopoulos, K. (2002). Haematopoietic cell-fate decisions, chromatin regulation and ikaros. 
Nat Rev Immunol 2, 162-174. 
51 
 
 
Hill, D.A., Siracusa, M.C., Abt, M.C., Kim, B.S., Kobuley, D., Kubo, M., Kambayashi, T., 
LaRosa, D.F., Renner, E.D., Orange, J.S., et al. (2012). Commensal bacteria-derived signals 
regulate basophil hematopoiesis and allergic inflammation. Nat Med 18, 538-546. 
Hooper, L.V., and Macpherson, A.J. (2010). Immune adaptations that maintain homeostasis 
with the intestinal microbiota. Nat Rev Immunol 10, 159-169. 
Ichinohe, T., Pang, I.K., Kumamoto, Y., Peaper, D.R., Ho, J.H., Murray, T.S., and Iwasaki, A. 
(2011). Microbiota regulates immune defense against respiratory tract influenza A virus 
infection. Proc Natl Acad Sci U S A 108, 5354-5359. 
Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, 
K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of Intestinal Th17 Cells by Segmented 
Filamentous Bacteria. Cell 139, 485-498. 
Ivanov, I.I., Frutos, R.d.L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., Finlay, B.B., 
and Littman, D.R. (2008). Specific Microbiota Direct the Differentiation of IL-17-Producing 
T-Helper Cells in the Mucosa of the Small Intestine. Cell Host & Microbe 4, 337-349. 
Jakobsson, H.E., Jernberg, C., Andersson, A.F., Sjolund-Karlsson, M., Jansson, J.K., and 
Engstrand, L. (2010). Short-term antibiotic treatment has differing long-term impacts on the 
human throat and gut microbiome. PLoS One 5, e9836. 
Jenkins, S.J., Ruckerl, D., Cook, P.C., Jones, L.H., Finkelman, F.D., van Rooijen, N., 
MacDonald, A.S., and Allen, J.E. (2011). Local macrophage proliferation, rather than 
recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284-1288. 
Kahrstrom, C.T. (2013). Entering a post-antibiotic era? Nat Rev Micro 11, 146-146. 
52 
 
 
Kamada, N., Kim, Y.G., Sham, H.P., Vallance, B.A., Puente, J.L., Martens, E.C., and Nunez, 
G. (2012). Regulated virulence controls the ability of a pathogen to compete with the gut 
microbiota. Science 336, 1325-1329. 
Kamada, N., Seo, S.-U., Chen, G.Y., and Nunez, G. (2013). Role of the gut microbiota in 
immunity and inflammatory disease. Nat Rev Immunol 13, 321-335. 
Kastenmuller, W., Torabi-Parizi, P., Subramanian, N., Lammermann, T., and Germain, R.N. 
(2012). A spatially-organized multicellular innate immune response in lymph nodes limits 
systemic pathogen spread. Cell 150, 1235-1248. 
Kau, A.L., Ahern, P.P., Griffin, N.W., Goodman, A.L., and Gordon, J.I. (2011). Human 
nutrition, the gut microbiome and the immune system. Nature 474, 327-336. 
Khosravi, A., and Mazmanian, S.K. (2013). Disruption of the gut microbiome as a risk factor 
for microbial infections. Current Opinion in Microbiology 16, 221-227. 
Khosravi, A., Yanez, A., Price, J.G., Chow, A., Merad, M., Goodridge, H.S., and Mazmanian, 
S.K. (2014). Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host 
Microbe 15, 374-381. 
Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., and 
Flavell, R.A. (2005). Nod2-Dependent Regulation of Innate and Adaptive Immunity in the 
Intestinal Tract. Science 307, 731-734. 
Lee, Y.K., Menezes, J.S., Umesaki, Y., and Mazmanian, S.K. (2011). Proinflammatory T-cell 
responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl 
Acad Sci U S A 108 Suppl 1, 4615-4622. 
53 
 
 
Lodinova-Zadnikova, R., and Sonnenborn, U. (1997). Effect of preventive administration of a 
nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial 
pathogens in newborn infants. Biology of the neonate 71, 224-232. 
Loo, V.G., Poirier, L., Miller, M.A., Oughton, M., Libman, M.D., Michaud, S., Bourgault, 
A.M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005). A predominantly clonal multi-
institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and 
mortality. The New England journal of medicine 353, 2442-2449. 
Lupp, C., Robertson, M.L., Wickham, M.E., Sekirov, I., Champion, O.L., Gaynor, E.C., and 
Finlay, B.B. (2007). Host-Mediated Inflammation Disrupts the Intestinal Microbiota and 
Promotes the Overgrowth of Enterobacteriaceae. Cell Host & Microbe 2, 119-129. 
Macpherson, A.J., and Uhr, T. (2004). Induction of Protective IgA by Intestinal Dendritic 
Cells Carrying Commensal Bacteria. Science 303, 1662-1665. 
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L.A., Iimura, M., Kagnoff, M.F., Eckmann, L., and 
Karin, M. (2005). Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß 
Processing. Science 307, 734-738. 
Massberg, S., Schaerli, P., Knezevic-Maramica, I., Kollnberger, M., Tubo, N., Moseman, E.A., 
Huff, I.V., Junt, T., Wagers, A.J., Mazo, I.B., et al. (2007). Immunosurveillance by 
hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 
131, 994-1008. 
Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L. (2005). An 
immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune 
system. Cell 122, 107-118. 
54 
 
 
Mazmanian, S.K., Round, J.L., and Kasper, D.L. (2008). A microbial symbiosis factor prevents 
intestinal inflammatory disease. Nature 453, 620-625. 
Moreau, M.C., Ducluzeau, R., Guy-Grand, D., and Muller, M.C. (1978). Increase in the 
population of duodenal immunoglobulin A plasmocytes in axenic mice associated with 
different living or dead bacterial strains of intestinal origin. Infect Immun 21, 532-539. 
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M.J., Salcedo, R., Kastenmuller, W., Deming, C., 
Quinones, M., Koo, L., Conlan, S., et al. (2012). Compartmentalized control of skin immunity 
by resident commensals. Science 337, 1115-1119. 
Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, 
N., Choudhury, B., Weimer, B.C., Monack, D.M., et al. (2013). Microbiota-liberated host sugars 
facilitate post-antibiotic expansion of enteric pathogens. Nature advance online publication. 
Olszak, T., An, D., Zeissig, S., Vera, M.P., Richter, J., Franke, A., Glickman, J.N., Siebert, R., 
Baron, R.M., Kasper, D.L., et al. (2012). Microbial Exposure During Early Life Has Persistent 
Effects on Natural Killer T Cell Function. Science 336, 489-493. 
Pamer, E.G. (2004). Immune responses to Listeria monocytogenes. Nat Rev Immunol 4, 812-
823. 
Petersson, J., Schreiber, O., Hansson, G.C., Gendler, S.J., Velcich, A., Lundberg, J.O., Roos, S., 
Holm, L., and Phillipson, M. (2011). Importance and regulation of the colonic mucus barrier in 
a mouse model of colitis. American journal of physiology Gastrointestinal and liver physiology 
300, G327-333. 
Portnoy, D.A., Schreiber, R.D., Connelly, P., and Tilney, L.G. (1989). Gamma interferon limits 
access of Listeria monocytogenes to the macrophage cytoplasm. The Journal of Experimental 
Medicine 170, 2141-2146. 
55 
 
 
Rathinam, V.A.K., Vanaja, S.K., and Fitzgerald, K.A. (2012). Regulation of inflammasome 
signaling. Nat Immunol 13, 333-332. 
Robbins, C.S., Chudnovskiy, A., Rauch, P.J., Figueiredo, J.-L., Iwamoto, Y., Gorbatov, R., 
Etzrodt, M., Weber, G.F., Ueno, T., van Rooijen, N., et al. (2012). Extramedullary 
Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions. 
Circulation 125, 364-374. 
Rodrigues, N.P., Boyd, A.S., Fugazza, C., May, G.E., Guo, Y., Tipping, A.J., Scadden, D.T., 
Vyas, P., and Enver, T. (2008). GATA-2 regulates granulocyte-macrophage progenitor cell 
function. Blood 112, 4862-4873. 
Round, J.L., and Mazmanian, S.K. (2009). The gut microbiota shapes intestinal immune 
responses during health and disease. Nat Rev Immunol 9, 313-323. 
Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., 
Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008). Microbial flora 
drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal 
immune defense. Immunity 29, 958-970. 
Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., 
Prinz, M., Wu, B., Jacobsen, S.E., Pollard, J.W., et al. (2012). A lineage of myeloid cells 
independent of Myb and hematopoietic stem cells. Science 336, 86-90. 
Sekirov, I., Tam, N.M., Jogova, M., Robertson, M.L., Li, Y., Lupp, C., and Finlay, B.B. (2008). 
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric 
infection. Infect Immun 76, 4726-4736. 
Serbina, N.V., Hohl, T.M., Cherny, M., and Pamer, E.G. (2009). Selective expansion of the 
monocytic lineage directed by bacterial infection. J Immunol 183, 1900-1910. 
56 
 
 
Serbina, N.V., Salazar-Mather, T.P., Biron, C.A., Kuziel, W.A., and Pamer, E.G. (2003). 
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial 
infection. Immunity 19, 59-70. 
Serbina, N.V., Shi, C., and Pamer, E.G. (2012). Monocyte-mediated immune defense against 
murine Listeria monocytogenes infection. Adv Immunol 113, 119-134. 
Shi, C., Hohl, T.M., Leiner, I., Equinda, M.J., Fan, X., and Pamer, E.G. (2011). Ly6G+ 
neutrophils are dispensable for defense against systemic Listeria monocytogenes infection. J 
Immunol 187, 5293-5298. 
Sieweke, M.H., and Allen, J.E. (2013). Beyond Stem Cells: Self-Renewal of Differentiated 
Macrophages. Science 342. 
Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., 
Glickman, J.N., and Garrett, W.S. (2013). The microbial metabolites, short-chain fatty acids, 
regulate colonic Treg cell homeostasis. Science 341, 569-573. 
Stecher, B., Robbiani, R., Walker, A.W., Westendorf, A.M., Barthel, M., Kremer, M., Chaffron, 
S., Macpherson, A.J., Buer, J., Parkhill, J., et al. (2007). Salmonella enterica Serovar 
Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota. PLoS Biol 5, 
e244. 
Swirski, F.K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., 
Figueiredo, J.L., Kohler, R.H., Chudnovskiy, A., Waterman, P., et al. (2009). Identification of 
splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616. 
Ubeda, C., Taur, Y., Jenq, R.R., Equinda, M.J., Son, T., Samstein, M., Viale, A., Socci, N.D., 
van den Brink, M.R., Kamboj, M., et al. (2010). Vancomycin-resistant Enterococcus 
57 
 
 
domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes 
bloodstream invasion in humans. J Clin Invest 120, 4332-4341. 
Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R., 
Wakeland, E.K., and Hooper, L.V. (2011). The Antibacterial Lectin RegIIIγ Promotes the 
Spatial Segregation of Microbiota and Host in the Intestine. Science 334, 255-258. 
van Rooijen, N., Sanders, A., and van den Berg, T.K. (1996). Apoptosis of macrophages 
induced by liposome-mediated intracellular delivery of clodronate and propamidine. J 
Immunol Methods 193, 93-99. 
Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., 
Sitaraman, S.V., Knight, R., Ley, R.E., and Gewirtz, A.T. (2010). Metabolic Syndrome and 
Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5. Science 328, 228-231. 
Weissman, I.L. (1994). Developmental switches in the immune system. Cell 76, 207-218. 
Willing, B.P., Vacharaksa, A., Croxen, M., Thanachayanont, T., and Finlay, B.B. (2011). 
Altering host resistance to infections through microbial transplantation. PLoS One 6, e26988. 
Yanez, A., Goodridge, H.S., Gozalbo, D., and Gil, M.L. (2013). TLRs control hematopoiesis 
during infection. European journal of immunology 43, 2526-2533. 
 
 
